STERIS’ (TSE:STE – Free Report) – Analysts at Raymond James issued their FY2027 earnings per share (EPS) estimates for STERIS’ in a research note issued on Wednesday, March 12th. Raymond James analyst M. Barth forecasts that the company will earn $0.63 per share for the year. Raymond James also issued estimates for STERIS’’s FY2028 earnings at $0.66 EPS.
STE has been the topic of a number of other reports. Cormark upgraded STERIS’ to a “moderate buy” rating in a research note on Monday, January 6th. Atb Cap Markets raised shares of STERIS’ to a “strong-buy” rating in a research report on Sunday, December 22nd.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Recommended Stories
- Five stocks we like better than STERIS’
- Pros And Cons Of Monthly Dividend Stocks
- How to Build the Ultimate Everything ETF Portfolio
- Manufacturing Stocks Investing
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What is a Death Cross in Stocks?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
